title: Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation.
authors.forename: J B
authors.initials: JB
authors.lastname: Perz
authors.forename: A V
authors.initials: AV
authors.lastname: Kristen
authors.forename: A
authors.initials: A
authors.lastname: Rahemtulla
authors.forename: J
authors.initials: J
authors.lastname: Parameshwar
authors.forename: F-U
authors.initials: FU
authors.lastname: Sack
authors.forename: J F
authors.initials: JF
authors.lastname: Apperley
authors.forename: H
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: H A
authors.initials: HA
authors.lastname: Katus
authors.forename: T J
authors.initials: TJ
authors.lastname: Dengler
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D019653:Myeloablative Agonists / Q000008:administration & dosage; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D019653:Myeloablative Agonists; D008558:Melphalan